“…In the United States, more than 28% people are suffering from migraine headache (2). The triptans and nonsteroidal anti-inflammatory drugs have been found to provide a symptomatic relief in migraine (3). Rizatriptan benzoate is a selective 5-hydroxytriptamine (5-HT) 1B/1D receptor agonist which is used for the acute treatment of migraine in adults with or without aura (4).…”
The aim of present investigation was to develop a taste masked fast dissolving sublingual strips of rizatriptan benzoate. The fast dissolving strips (FDS) were prepared by solvent casting method using polyox N-10 and polyethylene glycol 400 (PEG 400) as polymer and plasticizer respectively. The FDS were evaluated for pH, folding endurance, tensile strength, moisture absorption, disintegration time and in vitro dissolution. All formulations were free from bubble and exhibited smooth appearance. The pH of the films was acidic. It was observed that increase in the concentration of polyox N-10 increased the disintegration time but reduced the dissolution rate. The formulation A2 showed all the evaluation parameters within the acceptable range and was considered as optimized formulation. The optimized formulation was subjected to the taste masking and stability study. The results of taste masking study indicated an efficient masking of the bitter taste of drug by the flavouring agents in the film. The formulation A2 was found to be stable for three months with an insignificant change in the drug content and mean dissolution time (MDT). The compatibility study performed using ATR-FTIR and DSC analysis indicated absence of any unusual interaction between drug and excipients used in formulation. Thus, the FDS comprised of polyox N-10 and PEG 400 may be a better alternative to the other available fast dissolving systems for delivery of rizatriptan benzoate.
“…In the United States, more than 28% people are suffering from migraine headache (2). The triptans and nonsteroidal anti-inflammatory drugs have been found to provide a symptomatic relief in migraine (3). Rizatriptan benzoate is a selective 5-hydroxytriptamine (5-HT) 1B/1D receptor agonist which is used for the acute treatment of migraine in adults with or without aura (4).…”
The aim of present investigation was to develop a taste masked fast dissolving sublingual strips of rizatriptan benzoate. The fast dissolving strips (FDS) were prepared by solvent casting method using polyox N-10 and polyethylene glycol 400 (PEG 400) as polymer and plasticizer respectively. The FDS were evaluated for pH, folding endurance, tensile strength, moisture absorption, disintegration time and in vitro dissolution. All formulations were free from bubble and exhibited smooth appearance. The pH of the films was acidic. It was observed that increase in the concentration of polyox N-10 increased the disintegration time but reduced the dissolution rate. The formulation A2 showed all the evaluation parameters within the acceptable range and was considered as optimized formulation. The optimized formulation was subjected to the taste masking and stability study. The results of taste masking study indicated an efficient masking of the bitter taste of drug by the flavouring agents in the film. The formulation A2 was found to be stable for three months with an insignificant change in the drug content and mean dissolution time (MDT). The compatibility study performed using ATR-FTIR and DSC analysis indicated absence of any unusual interaction between drug and excipients used in formulation. Thus, the FDS comprised of polyox N-10 and PEG 400 may be a better alternative to the other available fast dissolving systems for delivery of rizatriptan benzoate.
“…According to the American Migraine Prevalence and Prevention (AMPP) Study, approximately 12% of adults suffer with migraine in the United States . And it is thought to be prevalent in up to 10% of the pediatric population . This often debilitating neurological condition also carries high disability.…”
“…Pharmacologic therapy can be helpful in treating and preventing chronic headaches . However, medications alone are not consistently effective at preventing headache in children and adolescents .…”
Section: Introductionmentioning
confidence: 99%
“…5 Pharmacologic therapy can be helpful in treating and preventing chronic headaches. 6 However, medications alone are not consistently effective at preventing headache in children and adolescents. 7 Prior studies suggest that nonmedical therapy is an important component of care, particularly in patients with significant disability due to headache.…”
Based on our retrospective chart review study, group education on headache evaluation and lifestyle management has potential as an effective, low-cost intervention for treatment of chronic headaches among adolescents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.